Advertisement
U.S. markets open in 3 hours 7 minutes

Item 9 Labs Corp. (INLB)

Other OTC - Other OTC Delayed Price. Currency in USD
0.0003-0.0001 (-28.57%)
At close: 03:57PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0003
Open0.0004
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0002 - 0.0004
52 Week Range0.0002 - 0.1400
Volume55,164,999
Avg. Volume16,669,481
Market Cap25,591
Beta (5Y Monthly)0.79
PE Ratio (TTM)N/A
EPS (TTM)-0.3300
Earnings DateMar 28, 2024 - Mar 30, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for INLB

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • ITEM 9 LABS CORP
    Analyst Report: Curaleaf Holdings, Inc.Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the U.S. The company has operations in 18 states. Its brands include Curaleaf, UKU, Select, and Grassroots. The company acquired EMMAC Life Sciences in March 2021, beginning its foray into the global medical market in competition with Canadian cannabis producers.
    Rating
    Fair Value
    Economic Moat
    6 days agoMorningstar
View more